Hubei NewZongke Viral Disease Control Bio-Tech Ltd.
PrivateLast Round
Series B
Oct 10, 2024
Total Funding Raised
$8.41M
Company Overview
Hubei NewZongke Viral Disease Control Bio-Tech Ltd. operates in Healthcare & Life Sciences and is based in Wuhan. Its latest recorded funding round was a Series B round in October 2024.
Hubei NewZongke Viral Disease Control Bio-Tech Ltd. is a biotechnology company that provides precision detection technology solutions, including open instrument platforms, fluorescent coded microspheres, and reagent solutions for life sciences and healthcare.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Precision Medicine, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hubei NewZongke Viral Disease Control Bio-Tech Ltd. Comparables
Compare Hubei NewZongke Viral Disease Control Bio-Tech Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wellgrow Technology | 87% | |
| Beijing Challen Biotechnology Co., Ltd. | 86% | |
| Suzhou VDO Biotech Co., Ltd. | 84% |
For institutional investors. Book with your work email.
Hubei NewZongke Viral Disease Control Bio-Tech Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 10, 2024 | ||||
| Corporate Funding | Sep 18, 2024 | ||||
| Series A | Nov 1, 2018 | ||||
| Angel | Jun 28, 2016 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 81% MoM.
- Oct 10, 2024
$4M round led by 科来思（深圳）科技有限公司
For institutional investors. Book with your work email.
Hubei NewZongke Viral Disease Control Bio-Tech Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hubei NewZongke Viral Disease Control Bio-Tech Ltd.'s valuation, stock price, and market status.
Is Hubei NewZongke Viral Disease Control Bio-Tech Ltd. a public or private company?
Hubei NewZongke Viral Disease Control Bio-Tech Ltd. is a private company.
What is the current stock price of Hubei NewZongke Viral Disease Control Bio-Tech Ltd.?
Hubei NewZongke Viral Disease Control Bio-Tech Ltd. is a private company, so its shares have no public market price. Caplight tracks Hubei NewZongke Viral Disease Control Bio-Tech Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hubei NewZongke Viral Disease Control Bio-Tech Ltd. worth (valuation)?
Valuation information for Hubei NewZongke Viral Disease Control Bio-Tech Ltd. is not publicly available.
Can I buy Hubei NewZongke Viral Disease Control Bio-Tech Ltd. stock?
Hubei NewZongke Viral Disease Control Bio-Tech Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hubei NewZongke Viral Disease Control Bio-Tech Ltd.'s last funding round?
Hubei NewZongke Viral Disease Control Bio-Tech Ltd.'s most recent funding round was Series B on October 10, 2024.
Who are the main investors in Hubei NewZongke Viral Disease Control Bio-Tech Ltd.?
Investor information for Hubei NewZongke Viral Disease Control Bio-Tech Ltd. is not publicly disclosed.
Will Hubei NewZongke Viral Disease Control Bio-Tech Ltd. IPO soon?
No public IPO plans have been announced for Hubei NewZongke Viral Disease Control Bio-Tech Ltd..
How can I track Hubei NewZongke Viral Disease Control Bio-Tech Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Hubei NewZongke Viral Disease Control Bio-Tech Ltd.'s shares on secondary markets.